Evidence map›Paper›PMID 31729434›Full record

ArticleScientific reports2019

Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery.

Meta A Simon, Erlina Anggraeni, Felycia Edi Soetaredjo, Shella Permasari Santoso, Wenny Irawaty, Truong Chi Thanh, Sandy Budi Hartono, Maria Yuliana, Suryadi Ismadji

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Nanoscale Drug Delivery Systems in Glioblastoma.Nanoscale research letters · 2022
    Review
  17. Preparation of MnRSC advances · 2021
    Article
  18. Extraction of Au(III) by Microbially Reduced Metal-Organic Frameworks.Langmuir : the ACS journal of surfaces and colloids · 2021
    Article
  19. Metal-organic frameworks for advanced drug delivery.Acta pharmaceutica Sinica. B · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Meta A SimonDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia.
Erlina AnggraeniDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia.
Felycia Edi SoetaredjoDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia. felyciae@yahoo.com.
Shella Permasari SantosoDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia.
Wenny IrawatyDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia.
Truong Chi ThanhDepartment of Chemical Engineering, 3-2 Street, Can Tho University, Can Tho City, Vietnam.
Sandy Budi HartonoDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia.
Maria YulianaDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia.
Suryadi IsmadjiDepartment of Chemical Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya, 60114, Indonesia. suryadiismadji@yahoo.com.
Universitas Katolik Widya Mandala Surabaya · IDCan Tho University · VNNational Taiwan University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sustainable development of drug delivery materials with good biocompatibility and controlled-release is a popular topic among researchers. In this research study, we demonstrated the potential of the metal-organic framework, that is MIL-100(Fe), as a drug delivery platform for isoniazid (INH). The MIL-100(Fe) was prepared by using the hydrofluoric acid-free hydrothermal method. Several physical measurements were conducted to characterize the MIL-100(Fe), including x-ray diffraction (XRD), scanning electron microscopy (SEM), nitrogen sorption, and thermal-gravimetric (TG). The synthesized MIL-100(Fe) has octahedron-shaped particles with superior properties, that is large surface area (1456.10 m

Indexed as

Drug Delivery SystemsAdsorptionAnimalsAntitubercular AgentsCell SurvivalDrug CarriersDrug LiberationIsoniazidKineticsLysergic Acid DiethylamideMetal-Organic FrameworksMiceModels, MolecularMolecular StructureNitrogenThermogravimetryAntitubercular AgentsDrug CarriersIsoniazidLysergic Acid DiethylamideMetal-Organic FrameworksN(1)-methyl-2-lysergic acid diethylamideNitrogen

Identifiers

PMID31729434
PMCPMC6858337
OpenAlexW2987247898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.